Wuxi Pharmatech (Cayman) Inc. Press Releases

WX 
$33.52
*  
0.06
0.18%
Get WX Alerts
*Delayed - data as of Jul. 11, 2014  -  Find a broker to begin trading WX now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Director Ying Han Resigns from WuXi Board
7/8/2014 4:30:00 PM - PR Newswire

WuXi AppTec Webinar on Breakthrough Drugs Draws Strong Attendance
6/23/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Toxicology Facility in Suzhou Passes FDA Inspection
6/20/2014 8:00:00 AM - PR Newswire

Health Care Sector Stocks Coverage -- Research on RadNet, IMS Health Holdings, WuXi PharmaTech Cayman, and Ventrus Biosciences
6/18/2014 7:50:00 AM - PR Newswire

WuXi PharmaTech Begins Operation of New High-Potency API Laboratory
5/28/2014 8:00:00 AM - PR Newswire

Targos Molecular Pathology GmbH and WuXi PharmaTech to Collaborate in Clinical Biomarker Services and Pathology Training in China
5/23/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Toxicology Facility in Suzhou Passes OECD GLP Inspection
5/21/2014 8:12:00 AM - PR Newswire

Technical Coverage on Health Care Equities -- Research on Novadaq Technologies, Rockwell Medical, Charles River Laboratories Intl., and WuXi PharmaTech Cayman
5/19/2014 10:59:00 AM - PR Newswire

WuXi PharmaTech Announces First-Quarter 2014 Results
5/14/2014 4:30:00 PM - PR Newswire

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility in Suzhou
5/13/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Completes Construction of New Materials Characterization Facility in St. Paul
5/12/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Begins Construction of New R&D and cGMP Manufacturing Campus in Changzhou
5/8/2014 8:26:00 AM - PR Newswire

FDA Approves Ibalizumab Manufactured by WuXi PharmaTech for Treatment of Patients on Expanded Access
5/5/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Receives 2013 Lilly Global Supplier Award
5/1/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Facilities for Late- and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Pass FDA Audit
4/30/2014 8:00:00 AM - PR Newswire

WuXi PharmaTech Breaks Ground on New Cell Therapy Manufacturing Facility
4/29/2014 8:23:00 AM - PR Newswire

WuXi PharmaTech Schedules First-Quarter 2014 Earnings Release
4/22/2014 7:39:00 AM - PR Newswire

Health Care Equities under Review -- Research on PerkinElmer, Quintiles Transnational Holdings, WuXi PharmaTech Cayman, and ICON
4/15/2014 12:54:00 PM - PR Newswire

WuXi PharmaTech Files 2013 Annual Report on Form 20-F
4/15/2014 8:44:00 AM - PR Newswire

WuXi PharmaTech Announces Management Appointments
4/15/2014 8:00:00 AM - PR Newswire